Menu

First Dengue Vax Approved

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

Dec 11, 2015
Kerry Grens

FREE STOCK PHOTOS, CDC/PROF FRANK HADLEY COLLINSMexico has approved the world’s first dengue virus vaccine. Sanofi’s Dengvaxia will be available to children over nine and adults 45 and under.

“We are making dengue a preventable disease, which makes us incredibly proud,” Olivier Charmeil, the head of vaccines at Sanofi, told Bloomberg Business.

According to the World Health Organization, 2.35 million people in the Americas contracted the mosquito-borne illness in 2013. Dengue can cause high fever, muscle pains, vomiting, and, in some cases, death.

Sanofi spent two decades and $1.6 billion on the development of Dengvaxia. According to BBC News, about 40,000 people in Mexico will initially receive the shot. “With this decision, Mexico moves ahead of all other countries, including France, to tackle the spread of this virus,” the country’s health ministry in a statement.

Results of a clinical trial among children found the vaccine is about 60 percent effective at warding off dengue virus.

The price of the immunization has not been disclosed. More than a dozen other countries are considering approval, according to Bloomberg News.

Update (December 29): Health officials in Brazil and the Philippines have also approved the use of Dengvaxia, Sanofi Pasteur announced over the past week.

“Approval of the first dengue vaccine is an important public health breakthrough with critical importance to our country, which bears the greatest dengue burden in Latin America,” Joao Bosco Siqueira Junior of the Federal University of Goias, Brazil, said in the press release.

Dengue cases in Brazil erupted in 2015, topping 1.5 million, compared to roughly 500,000 in 2014, The Wall Street Journal reported. Asia, however, bears the brunt of dengue fever, with 70 percent of infections occurring there.

It’s not clear when the vaccine will become available in the countries that have authorized its distribution.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.